Research Topics
| R BealeSummaryAffiliation: Guy's and St Thomas' NHS Foundation Trust Country: UK Publications
| Collaborators
|
Detail Information
Publications
Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trialRichard J Beale
Department of Adult Critical Care Medicine, Guy s and St Thomas Hospital, London, United Kingdom
Crit Care Med 36:131-44. 2008..To assess the safety and efficacy of an early enteral pharmaconutrition supplement containing glutamine dipeptides, antioxidative vitamins and trace elements, and butyrate in critically ill, septic patients...
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registryR Beale
Adult Intensive Care Unit, Guy s and St Thomas NHS Foundation Trust, St Thomas Hospital, Lambeth Palace Road, SE1 7EH, London, UK
Infection 37:222-32. 2009....
Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registryRichard Beale
Division of Asthma, King s College London, Guy s, Campus, Great Maze Pond, London SE1 9RT, UK
Crit Care 14:R102. 2010....
Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort studyMarius J Terblanche
Critical Care and Anaesthesia Research Group, King s College London, St Thomas Hospital, Westminster Bridge Road, London SE1 7EH, UK
Crit Care 15:R74. 2011..We tested the hypothesis that statin therapy, administered for standard clinical indications to ventilated intensive care unit patients, prevents acute organ failure without harming the liver...
Pitfalls in haemodynamic monitoring based on the arterial pressure waveformLuigi Camporota
Department of Adult Critical Care Guy s and St Thomas NHS Foundation Trust, St Thomas Hospital, 1st Floor East Wing Lambeth Palace Road, London, UK
Crit Care 14:124. 2010..In these conditions, we advocate the use of transpulmonary indicator dilution via a femoral artery...
Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapyLuigi Camporota
Adult Intensive Care Unit, Guy s and St Thomas NHS Foundation Trust, St Thomas Hospital, 1st Floor East Wing, Lambeth Palace Road, London SE1 7EH, UK
Crit Care 12:R163. 2008..The aim of this study was to analyse the filter survival time (FST), and to quantify the requirement of packed red cells (PRC) and blood products during DrotAA infusion...
The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomesGreg Martin
Division of Pulmonary, Allergy, and Critical Care, Emory University, Atlanta, Georgia 30322, USA
Crit Care 13:R103. 2009....
Outcomes of critically ill patients with cirrhosis admitted to intensive care: an important perspective from the non-transplant settingS J Thomson
Department of Hepatology, St George s Hospital, Tooting, London, UK
Aliment Pharmacol Ther 32:233-43. 2010..These tertiary reports could fuel a negative bias when patients with cirrhosis are reviewed for ICU admission in secondary care...
Immunologically enhanced enteral nutrition: current statusD Wyncoll
Adult Intensive Care Unit, Guy s and St Thomas Hospital Trust, St Thomas Hospital, Lambeth Palace Road, London, SE1 7EH, UK
Curr Opin Crit Care 7:128-32. 2001..Nevertheless, as new products become available they should be subjected to controlled clinical trials, especially because several of the mechanisms involved are not yet fully understood...
